Basic and preclinical research services
LIMR offers research services to research and affiliated faculty, incubating companies, and physicians throughout Main Line Health. Here, you will find information about various services.
Learn more about Basic and Preclinical Research Services
Center for Human Antibody Technology
The Center for Human Antibody Technology (CHAT) is a core facility that uses a powerful human antibody cloning platform technology developed by LIMR’s Scott Dessain, MD, PhD.
Learn more about the Center for Human Antibody Technology
LIMR Chemical Genomics Center
The mission of LIMR Chemical Genomics Center (LCGC) is to advance medicinal discovery. We provide proprietary, uniquely diverse, drug-like chemical libraries and other resources that measurably improve the efficiency of high throughput screening (HTS) by 500 percent, and potentially reveal unexpected drug synergies that may otherwise not be discovered.
Learn more about the LIMR Chemical Genomics Center
Biotechnology company incubator
Technology development at LIMR focuses on three main functions, including promoting the development and commercialization of discoveries through technology transfer, identifying new early-stage biotech companies and partnering with organizations in our community to increase awareness of LIMR and bring additional resources to our facility.
Learn more about our Biotechnology Company Incubator
Assessment of drug candidates’ cardiac QT liability
Before new drug candidates can be tested in humans, it is critical to assess whether they will provoke an irregular heart rhythm. Gan-Xin Yan, MD, PhD, has pioneered a method called "wedge prep" that uses slices of heart tissue from the adult ventricle of a rabbit to deliver quick, accurate testing.
LEARN MORE ABOUT ASSESSING CARDIAC QT LIABILITY
Office of Research Protections
The mission of the Office of Research Protections (ORP) is to forge a partnership with the Main Line Health research community to conduct safe and ethical research.